Leadership, Planning, and Evaluation (LPE)
- Institution
- SALK INSTITUTE FOR BIOLOGICAL STUDIES, CA
- Principal investigator
- Reuben Shaw
- Funding
- $252K
- Duration
- 1996–2029
Moonbase score
Still being scored
Abstract
At the Salk Cancer Center (SCC), overall responsibility for planning and evaluation rests with the Director, Reuben Shaw, PhD, who sets the vision and strategic processes to intensify the growth and impact of SCC’s cancer research, training, and community impact. Shaw transformed SCC’s Senior Leadership team in 2021 with well-defined roles and responsibilities, enhancing the culture of engagement, input, and continuous improvement. He embarked on refreshing SCC internal and external advisory committees and creating new ones. Internal advisory bodies currently include the Executive Committee (EC), Research Program Planning Committee, Shared Resource Management Group (SRMG), and Cancer Research Training & Education Coordination (CRTEC) Committee. The External Advisory Board (EAB) plays an essential role in the planning and evaluation process and has been revitalized in the current funding period. Informed by these committees, Senior Leaders led several evaluation and transformation processes during this cycle, including: 1) development of a new SCC Strategic Plan; 2) reassessment of SCC membership to improve cancer focus; 3) restructuring of Research Programs to achieve the goals of the Strategic Plan and foster transdisciplinary collaboration and impact; and 4) evaluation of Shared Resources. Building upon the successes of the prior strategic plan and to catalyze further strategic growth, the Specific Aims of Leadership, Planning, and Evaluation are: Aim 1. To lead efforts to execute the SCC Strategic Plan (2023-2028) Aim 2. To leverage the talent and multidisciplinary expertise of a strong, collaborative senior leadership team, as well as feedback from SCC members, Institute stakeholders, and internal/external advisory groups, to ensure continuous improvement and innovation within the SCC Research Programs, Shared Resources, education and training activities, and diversity initiatives. Aim 3. To lead efforts to develop and execute the next Strategic Plan (2028-2033), thereby ensuring continued excellence of the SCC. Impact: During the current grant period, these rigorous planning and evaluation mechanisms have promoted cohesion in planning and communication, guided proactive decision-making and new investments, and ensured close monitoring of progress and timely course-corrections to foster the significant achievements described in this component of the CCSG application. A major achievement during the current funding period was the recruitment of new faculty colleagues, including one full professor hire, five new assistant professors, and a new Salk fellow (straight from their PhD to an independent PI position).
LOADING MOONBASE SCORE
Questions for SALK INSTITUTE FOR BIOLOGICAL STUDIES
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Salk Institute for Biological StudiesNot yet scored
Pancreatitis-induced initiation of early onset pancreatic cancer
Reuben Shaw · $189K · 2025–2026
- NIH · Salk Institute for Biological StudiesNot yet scored
Project 3: The AMPK Autophagy Pathway as a Metabolic Liability in Pancratic Ductal Adenocarcinoma
Reuben Shaw · $467K · 2023–2028
- NIH · Salk Institute for Biological StudiesNot yet scored
Decoding And Targeting The LKB1-AMPK Signaling Pathway In Cancer
Reuben Shaw · $1.1M · 2017–2031